Details for 2016760801
Up to date per 04.04.2026
Actions
Details for 2016760801
Granted/Registered
European Patent
04.07.2018 A
25.02.2026 B1
24.08.2015
US
201562209000 P
12.10.2015
US
201562240131 P
29.10.2015
US
201562247906 P
02.11.2015
US
201562249497 P
C07K 16/24 20060101AFI20170316BHEP
Owner
GlaxoSmithKline Intellectual Property (No.2) LimitedGSK Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NYGB
Representative
No representatives present
Inventor
MONCK, Myrna A.709 Swedeland Road King of Prussia, PA 19406US
BAM, Narendra B.709 Swedeland Road King of Prussia, PA 19406US
DALLY, Jennifer709 Swedeland Road King of Prussia, PA 19406US
SPATARA, Michelle709 Swedeland Road King of Prussia, PA 19406US
Information about Fees